We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

22 hedge funds and large institutions have $7.34M invested in ImmuCell in 2019 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 22 → 22 (0)

0% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 4

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

2.34% less ownership

Funds ownership: 22.12% → 19.78% (-2.3%)

65% less capital inflows, than outflows

Capital inflows: $525K | Capital outflows: $1.49M

Holders
22
Holders Change
–
Holders Change %
0%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$224K
2
Strategic Financial Services
Strategic Financial Services
New York
+$145K
3
HighTower Advisors
HighTower Advisors
Illinois
+$77.2K
4
Renaissance Technologies
Renaissance Technologies
New York
+$72.2K
5
Tower Research Capital (TRC)
Tower Research Capital (TRC)
New York
+$4.83K

Top Sellers

Rank Fund Capital Flow
1
Heartland Advisors
Heartland Advisors
Wisconsin
-$975K
2
Wexford Capital
Wexford Capital
Florida
-$364K
3
PCM
Perritt Capital Management
Illinois
-$119K
4
Flagship Harbor Advisors
Flagship Harbor Advisors
Massachusetts
-$16K
5
UBS Group
UBS Group
Switzerland
-$9.38K

ICCC Hedge Fund Activity: Q4 2019 in Review

22 of the 5,094 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q4 2019, worth a combined $7.34M — down 17% from $8.86M a quarter earlier.

Fund positioning in ICCC was balanced in Q4 2019: 4 funds opened new positions, 4 closed out, 4 added to existing stakes and 4 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $224K. The largest seller was Heartland Advisors, exiting entirely with an estimated $975K sold.

  • 22 institutional investors held ImmuCell (ICCC) as of Q4 2019, unchanged from Q3 2019.
  • Funds reported $7.34M of ImmuCell stock for Q4 2019, down 17% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q4 2019 and 4 closed out, a net change of 0 holders.
  • The largest ImmuCell buyer in Q4 2019 was Morgan Stanley, an estimated $224K added.
  • The largest ImmuCell seller in Q4 2019 was Heartland Advisors, an estimated $975K sold.

Based on aggregated 13F filings for Q4 2019.